| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |